Atsena Therapeutics has received fast track designation from the FDA for ATSN-201, aimed at treating X-linked retinoschisis (XLRS).

This approach ensures the elimination of the surgical risks typically associated with foveal detachment ... laterally from the subretinal injection area allows treatment beyond the macula.

Interestingly, though, further analysis seemed to show an improvement in lesion reduction scores over time: While the primary endpoint of mean rate of change (slope) in GA lesion area compared to ...

This approach leverages eye-tracking techniques to determine where the user is looking, allowing the system to render high-resolution graphics only in the foveal region—the small area of the retina ...

Note that the stacked foveal patches may not have been cropped from the same physical area because the stacks included past foveal visual frames subject to time-dependent fovea movements. Visual ...

This study also did not find a significant correlation between preoperative central foveal thickness, presence of a macular ... active research in this area is being pursued.34 Finally, swept source ...